The effect of specific hormones on fibrinolysis in pregnancy

American Journal of Obstetrics and Gynecology

Volumn 175, Issue 1, 1996, Pages 168-172

  Houlihan, C M ^a   Knuppel, R A ^a   Vintzileos, A M ^a   Guo, J Z ^a   Do Won Hahn, ^a  

^a NONE   (United States)

Author keywords

endothelium; estradiol 17 ; hydrocortisone; plasminogen activator inhibitor 1; pregnancy; progesterone; prolactin; Tissue type plasminogen activator

Indexed keywords

ESTRADIOL; HYDROCORTISONE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGESTERONE; PROLACTIN; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FIBRINOLYSIS; HEMATOLOGICAL PARAMETERS; HORMONE ACTION; HUMAN; HUMAN CELL; PREGNANCY; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY; THROMBOGENESIS; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VEIN THROMBOSIS;

EID: 0029787776     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(96)70269-7     Document Type: Article

References (26)

1. J. Bonnar Venous thromboembolism in pregnancy Clin Obstet Gynecol 8 1981 455 473
2. P Treffers B Huidekoper G Weenink G. Kloosterman Epidemiological observations of thromboembolic disease during pregnancy and in the puerperium in 56,022 women Int J Gynecol Obstet 21 1983 327 331
3. K. Montella Hypercoagulable states in pregnancy Curr Obsted Med 2 1993 141 162
4. P Andreasen B Georg L Lund A Riccio S. Stacey Plasminogen activator inhibitors: hormonally regulated serpins Mol Cell Endocrinol 68 1990 1 19
5. A Estelles J Gilabert M Keaton Y Eguchc J Aznar S Granchla Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation Blood 84 1994 143 150
6. A Estelles J Gilabert F Espana J Aznar M. Galbis Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia Am J Obstet Gynecol 165 1991 138 142
7. J Bonnar L Daly B. Sheppard Changes in the fibrinolytic system during pregnancy Semin Thromb Hemost 16 1990 221 229
8. J Biezenski H. Moore Fibrinolysis in normal pregnancy J Clin Pathol 11 1958 306 310
9. E Kruihof C Tran-Thang A Gudinchet J Hauert G Nicoloso C Genton Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors Blood 69 1987 460 466
10. H Lau J Teitel T Cheung SK Kung M. Garvey Hypofibrinolysis in patients with hypercoagulability: the roles of urokinase and of plasminogen activator inhibitor Am J Hematol 44 1993 260 265
11. L Engebretsen P Kierulf P. Brandtzaeg Extreme plasminogen activator inhibitor and endotoxin values in patients with meningococcal disease Thromb Res 42 1986 713 716
12. A Hamsten G UdeFaire G Walldius G Dahlen A Syamori C Landou Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction Lancet 2 1987 3 8
13. A Halligan J Bonnar B Sheppard M Darling J. Walshe Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia Br J Obstet Gynaecol 101 1994 488 492
14. S Fujii C Lucore W Hopkins J Billadello B. Sobel Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells Thromb Haemost 64 1990 412 419
15. P Quehenberger S Kapiotis C Partan B Schneider B Wenzel A Gaiger Studies on oral contraceptives - induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells Ann Hematol 67 1993 33 36
16. T Kooistra P Bosma J Jespersen C. Kluft Studies on the mechanism of action of oral contraceptives with regard to fibrinolytic variables Am J Obstet Gynecol 163 1990 404 412
17. J Leuven C Kluft R Bertina L. Hessel Effects of two low-dose oral contraceptives on circulating components of the coagulation and fibrinolytic systems J Lab Clin Med 109 1987 631 636
18. A Sabra J. Bonnar Hemostatic system changes induced by 50 mg and 30 mg estrogen/progestrogen oral contraceptives J Reprod Med 28 1983 85 91
19. D Crutchley L Conanan JR. Maynard Human fibroblasts produce inhibitor directed against plasminogen activator when treated with glucocorticoids Ann N Y Acad Sci 370 1981 609 616
20. D Loskutoff K Roegner L Erickson R Schleef A Huttenlocher P Coleman The dexamethasone induced inhibitor of plasminogen activator in hepatoma cells is antigenically related to an inhibitor produced by bovine aortic endothelial cells Thromb Haemost 55 1986 8 11
21. J Van Giezen J. Jansen Correlation of in vitro and in vivo decreased fibrinolytic activity caused by dexamethasone Ann N Y Acad Sci 667 1992 199 201
22. J Van Giezen J. Jansen Inhibition of fibrinolytic activity in vivo by dexamethasone is counterbalanced by an inhibition of platelet aggregation Thromb Haemost 68 1992 69 73
23. KW VonEickstedt W. Elsasser Corticotrophins and corticosteroids 11th ed M Dukes Meyler's side effects of drugs. 1988 Elsevier New York 812 827
24. D. Hadden Adrenal disorders of pregnancy Endocrinol Metab Clin North Am 24 1995 139 151
25. D Aron A Schnall L. Sheeler Cushing's syndrome and pregnancy Am J Obstet Gynecol 162 1990 244 252
26. P Crowley I Chalmers M. Keirse The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials Br J Obstet Gynaecol 97 1990 11 25